otch2b2 pdei2
Name
pdei1
Label
Phosphodiesterase Inhibitors (SHHS1)
Description

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the SHHS1 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
erectile dysfunction PDEI1
Phosphodiesterase Inhibitors (SHHS1) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,688 - - -
Yes 98 - - -
Unknown 18 - - -
Phosphodiesterase Inhibitors (SHHS1) vs Age at SHHS1
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 333 1,003 1,746 1,581 923 102 5,688
Yes 3 10 20 34 29 2 98
Unknown 6 4 3 2 3 - 18
Phosphodiesterase Inhibitors (SHHS1) vs Gender
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,704 2,984 5,688
Yes 50 48 98
Unknown 11 7 18
Phosphodiesterase Inhibitors (SHHS1) vs Race
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,812 497 379 5,688
Yes 85 13 - 98
Unknown 10 5 3 18